InvestorsHub Logo

min

Followers 0
Posts 8
Boards Moderated 0
Alias Born 10/26/2004

min

Re: DewDiligence post# 599

Tuesday, 11/02/2010 6:43:14 PM

Tuesday, November 02, 2010 6:43:14 PM

Post# of 20689
The Motly Fool suggests that Sanofi will cut price on Lovenox. Question: MNTA made a point of their 40-45% capacity. Could that have been a message to Sanofi that enoxaparin will stay at that market share as long as Sanofi doesn't lower price or introduce a generic?